Booty LM, Gawel JM, Cvetko F, Caldwell ST, Hall AR, Mulvey JF, et al
The key findings from this clinical program include significant reductions in body weight and fat mass in treatment groups compared to placebo, preferential loss of abdominal and visceral adipose tissue, no changes in serum IGF-1 levels at any dose tested, no negative effects on glucose metabolism or insulin sensitivity, no significant adverse events related to metabolic or endocrine disruption, and safety profile indistinguishable from placebo for most parameters
Stroke 48(7):19411947 Xi T, Jin F, Zhu Y, Wang J, Tang L, Wang Y et al (2017) MicroRNA-126-3p attenuates blood-brain barrier disruption, cerebral edema and neuronal injury following intracerebral hemorrhage by regulating PIK3R2 and Akt
Sun Q, Sun L, Liu HH, Chen X, Seth RB, Forman J, Chen ZJ (2006) The specific and essential role of MAVS in antiviral innate immune responses
Tak, dugotrwaa suplementacja wysokimi dawkami glutationu moe zmniejsza poziom cynku, poniewa obie te substancje s zaangaowane w szlaki antyoksydacyjne organizmu